Chugai Pharmaceutical Co., Ltd.
4519.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥11,518 | ¥8,789 | ¥5,540 | ¥6,141 |
| - Cash | ¥540 | ¥459 | ¥222 | ¥268 |
| + Debt | ¥11 | ¥13 | ¥14 | ¥16 |
| Enterprise Value | ¥10,989 | ¥8,343 | ¥5,332 | ¥5,889 |
| Revenue | ¥1,171 | ¥1,111 | ¥1,260 | ¥1,000 |
| % Growth | 5.3% | -11.8% | 26% | – |
| Gross Profit | ¥831 | ¥693 | ¥783 | ¥660 |
| % Margin | 71% | 62.4% | 62.2% | 66% |
| EBITDA | ¥575 | ¥476 | ¥563 | ¥450 |
| % Margin | 49.1% | 42.8% | 44.7% | 45% |
| Net Income | ¥387 | ¥325 | ¥374 | ¥303 |
| % Margin | 33.1% | 29.3% | 29.7% | 30.3% |
| EPS Diluted | 235.36 | 197.8 | 227.57 | 184.17 |
| % Growth | 19% | -13.1% | 23.6% | – |
| Operating Cash Flow | ¥448 | ¥410 | ¥244 | ¥280 |
| Capital Expenditures | -¥51 | -¥74 | -¥71 | -¥73 |
| Free Cash Flow | ¥397 | ¥336 | ¥173 | ¥207 |